Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.69 HKD
1.88 B HKD
10.53 B HKD
999.80 M
About GRAND PHARMACEUTICAL GROUP LTD
Sector
CEO
Chao Zhou
Headquarters
Hong Kong
Website
Founded
1995
FIGI
BBG000C3NM14
Grand Pharmaceutical Group Ltd. is an investment holding company, which engages in the development, manufacture and distribution of pharmaceutical products. Its products offer ophthalmic medicines for anti-bacterial, antibiotics, antipyretic and analgesic use. It operates through the following geographical segments: The People's Republic of China (PRC), America, Europe, Asia other than the PRC, and Others. The company was founded on October 18, 1995 and is headquartered in Hong Kong.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 512 is 4.45 HKD — it has decreased by −1.72% in the past 24 hours. Watch GRAND PHARMACEUTICAL GROUP LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange GRAND PHARMACEUTICAL GROUP LTD stocks are traded under the ticker 512.
512 stock has fallen by −6.94% compared to the previous week, the month change is a −3.59% fall, over the last year GRAND PHARMACEUTICAL GROUP LTD has showed a −0.89% decrease.
We've gathered analysts' opinions on GRAND PHARMACEUTICAL GROUP LTD future price: according to them, 512 price has a max estimate of 6.20 HKD and a min estimate of 5.40 HKD. Watch 512 chart and read a more detailed GRAND PHARMACEUTICAL GROUP LTD stock forecast: see what analysts think of GRAND PHARMACEUTICAL GROUP LTD and suggest that you do with its stocks.
512 stock is 2.92% volatile and has beta coefficient of 0.88. Track GRAND PHARMACEUTICAL GROUP LTD stock price on the chart and check out the list of the most volatile stocks — is GRAND PHARMACEUTICAL GROUP LTD there?
Today GRAND PHARMACEUTICAL GROUP LTD has the market capitalization of 15.97 B, it has decreased by −3.80% over the last week.
Yes, you can track GRAND PHARMACEUTICAL GROUP LTD financials in yearly and quarterly reports right on TradingView.
GRAND PHARMACEUTICAL GROUP LTD is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
512 net income for the last half-year is 1.56 B HKD, while the previous report showed 850.64 M HKD of net income which accounts for 83.15% change. Track more GRAND PHARMACEUTICAL GROUP LTD financial stats to get the full picture.
Yes, 512 dividends are paid annually. The last dividend per share was 0.26 HKD. As of today, Dividend Yield (TTM)% is 5.70%. Tracking GRAND PHARMACEUTICAL GROUP LTD dividends might help you take more informed decisions.
GRAND PHARMACEUTICAL GROUP LTD dividend yield was 6.36% in 2023, and payout ratio reached 48.51%. The year before the numbers were 3.04% and 23.85% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has 10.53 K employees. See our rating of the largest employees — is GRAND PHARMACEUTICAL GROUP LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GRAND PHARMACEUTICAL GROUP LTD EBITDA is 2.95 B HKD, and current EBITDA margin is 29.02%. See more stats in GRAND PHARMACEUTICAL GROUP LTD financial statements.
Like other stocks, 512 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GRAND PHARMACEUTICAL GROUP LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GRAND PHARMACEUTICAL GROUP LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GRAND PHARMACEUTICAL GROUP LTD stock shows the neutral signal. See more of GRAND PHARMACEUTICAL GROUP LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.